Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy

BackgroundLow risk prostate cancers are commonly treated with low dose rate (LDR) brachytherapy involving I-125 seeds. The implementation of a ‘live-planning’ technique at the Royal Adelaide Hospital (RAH) in 2007 enabled the completion of the whole procedure (i.e. scanning, planning and implant) in one sitting. ‘Live-planning’ has the advantage of a more reliable delivery of the planned treatment compared to the ‘traditional pre-plan’ technique (where patient is scanned and planned in the weeks prior to implant). During live planning, the actual implanted needle positions are updated real-time on the treatment planning system and the dosimetry is automatically recalculated. The aim of this investigation was to assess the differences and clinical relevance between the planned dosimetry and the updated real-time implant dosimetry.MethodsA number of 162 patients were included in this dosimetric study. A paired t-test was performed on the D90, V100, V150 and V200 target parameters and the differences between the planned and implanted dose distributions were analysed. Similarly, dosimetric differences for the organs at risk (OAR) were also evaluated.ResultsSmall differences between the primary dosimetric parameters for the target were found. Still, the incidence of hotspots was increased with approximately 20% for V200. Statistically significant increases were observed in the doses delivered to the OAR between the planned and implanted data; however, these increases were consistently below 3% thus probably without clinical consequences.ConclusionsThe current study assessed the accuracy of prostate implants with I-125 seeds when compared to initial plans. The results confirmed the precision of the implant technique which RAH has in place. Nevertheless, geographical misses, anatomical restrictions and needle displacements during implant can have repercussions for centres without live-planning option if dosimetric changes are not taken into consideration.

[1]  Alex Rijnders,et al.  Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[3]  T. Rutten,et al.  Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation. , 2012, Medical physics.

[4]  G. Gustafson,et al.  Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. , 1995, International journal of radiation oncology, biology, physics.

[5]  P. Hoskin,et al.  Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  A. D'Amico,et al.  Optimizing target coverage by dosimetric feedback during prostate brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[7]  J. Ciezki,et al.  Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[8]  [Improvement of interstitial brachytherapy for localized prostate neoplasms with a new implantation technique]. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[9]  F. Bartone,et al.  Transperineal percutaneous I-125 implant of prostate. , 1981, Urology.

[10]  S. Sim,et al.  Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose. , 2004, International journal of radiation oncology, biology, physics.

[11]  Wayne M Butler,et al.  American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. , 2012, Brachytherapy.

[12]  Alvaro Martinez,et al.  Conformal prostate brachytherapy guided by realtime dynamic dose calculations using permanent 125iodine implants: technical description and preliminary experience. , 2006, Archivos espanoles de urologia.

[13]  R. Stock,et al.  Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant. , 2000, Techniques in urology.